BSE - SMEListed
Sudarshan Pharma Industries Limited
Company websiteSudarshan Pharma Industries Limited plans to raise ₹68,62,400 crore via IPO. That includes a fresh infusion of ₹68,62,400 crore and an OFS worth ₹0 crore.
Apply from 09-03-2023 until 14-03-2023. Allotment and tentative listing are scheduled for 18-03-2023 and 20-03-2023. Quick tip: check lot size and valuation before bidding.
Start Date09-03-2023
End Date14-03-2023
Listing Date20-03-2023
Allotment Date18-03-2023
Current Price₹73
GMP₹0 (0.00%)
Lot Size1600 Shares
Subscription1.06 Times
Face Value₹10 per share
Listing atBSE
Issue Price₹71 - ₹73
Pre Issue₹95,46,998
Post Issue₹1,29,86,998
Issue Size₹68,62,400
(aggregating up to 50.10 Cr)
(aggregating up to 50.10 Cr)
Fresh Issue₹68,62,400
(aggregating up to 50.10 Cr)
(aggregating up to 50.10 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Sudarshan Pharma Industries Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹71 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
12 Nov 2025, 08:11 | ₹73 | ₹0 | ₹73 (0.00%) |
25 Mar 2025, 04:59 | ₹73 | ₹0 | ₹73 (0.00%) |
Financials overview In Lakhs
Here is a quick look at the recent financial performance of Sudarshan Pharma Industries Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
The IPO reservation for Sudarshan Pharma Industries Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
QIB | 18.98% | 13,02,400 |
NII (HNI) | 22.80% | 15,64,800 |
RETAIL | 53.21% | 36,51,200 |
Market Maker | 5.01% | 3,44,000 |
TOTAL | 100.00% | 68,62,400 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 1,600 | ₹1,16,800 | |
HNI | 2 | 3,200 | ₹2,33,600 |
Below you can find the official contact details of Sudarshan Pharma Industries Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Phone: 022- 42221111
Website: http://www.sudarshanpharma.com/
Address: 301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai - 400092
IPO Registrar
Name: Kfin Technologies Limited
Phone: 04067162222
Email: einward.ris@kfintech.com
Website: https://karisma.kfintech.com/